Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung

Real-time visualization of immune cell clearance of Aspergillus fumigatus spores and hyphae

(2017) Benjamin P. Knox et al.   FUNGAL GENETICS AND BIOLOGY

Type I IFN Inhibits Alternative Macrophage Activation duringMycobacterium tuberculosisInfection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling

(2016) Lúcia Moreira-Teixeira et al.   JOURNAL OF IMMUNOLOGY

Type IIFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human

(2015) Lisa Andzinski et al.   INTERNATIONAL JOURNAL OF CANCER

Cryptococcus neoformans–Induced Macrophage Lysosome Damage Crucially Contributes to Fungal Virulence

(2015) Michael J. Davis et al.   JOURNAL OF IMMUNOLOGY

Human Neutrophils Use Different Mechanisms To KillAspergillus fumigatusConidia and Hyphae: Evidence from Phagocyte Defects

(2015) Roel P. Gazendam et al.   JOURNAL OF IMMUNOLOGY

Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs

(2015) Rachid Ammi et al.   PHARMACOLOGY & THERAPEUTICS

Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis

(2015) Edward Sionov et al.   PLoS Pathogens

Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series

(2014) Corine E Delsing et al.   BMC INFECTIOUS DISEASES

Genetic Relatedness versus Biological Compatibility between Aspergillus fumigatus and Related Species

(2014) J. A. Sugui et al.   JOURNAL OF CLINICAL MICROBIOLOGY

IFN- /  Signaling Is Required for Polarization of Cytokine Responses toward a Protective Type 1 Pattern during Experimental Cryptococcosis

(2014) C. Biondo et al.   JOURNAL OF IMMUNOLOGY

Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial

(2014) A. M. Salazar et al.   Cancer Immunology Research

Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis

(2013) Thomas Lehrnbecher et al.   CURRENT PHARMACEUTICAL DESIGN

Interferon-β Production via Dectin-1-Syk-IRF5 Signaling in Dendritic Cells Is Crucial for Immunity to C. albicans

(2013) Carlos del Fresno et al.   IMMUNITY

Aspergillus tanneri sp. nov., a New Pathogen That Causes Invasive Disease Refractory to Antifungal Therapy

(2012) J. A. Sugui et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rare and new etiological agents revealed among 178 clinicalAspergillusstrains obtained from Czech patients and characterized by molecular sequencing

(2012) Vit Hubka et al.   MEDICAL MYCOLOGY

Hidden Killers: Human Fungal Infections

(2012) G. D. Brown et al.   Science Translational Medicine

Immunotherapy of aspergillosis

(2011) A. Carvalho et al.   CLINICAL MICROBIOLOGY AND INFECTION

Conventional Dendritic Cells Mount a Type I IFN Response against Candida spp. Requiring Novel Phagosomal TLR7-Mediated IFN-  Signaling

(2011) C. Bourgeois et al.   JOURNAL OF IMMUNOLOGY

Viral tricks to grid-lock the type I interferon system

(2010) Gijs A Versteeg et al.   CURRENT OPINION IN MICROBIOLOGY

Conidia but Not Yeast Cells of the Fungal Pathogen Histoplasma capsulatum Trigger a Type I Interferon Innate Immune Response in Murine Macrophages

(2010) D. O. Inglis et al.   INFECTION AND IMMUNITY

Epidemiology and Outcome of Invasive Fungal Diseases in Patients With Chronic Granulomatous Disease

(2010) Julien Beauté et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Invasive Aspergillosis Due toNeosartorya udagawae

(2009) Donald C. Vinh et al.   CLINICAL INFECTIOUS DISEASES

Innate Immunity to Aspergillus Species

(2009) S. J. Park et al.   CLINICAL MICROBIOLOGY REVIEWS

Invasive aspergillosis in chronic granulomatous disease

(2009) Brahm H. Segal et al.   MEDICAL MYCOLOGY

Twelve immunotherapy drugs that could cure cancers

(2008) Martin A. ‘Mac’ Cheever   IMMUNOLOGICAL REVIEWS